MESA LABORATORIES INC /CO/
For the period ended Mar 31, 2026. Filed Jun 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 3, 2026
MLAB$127.82-0.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share amounts)
| March 31, | March 31, | |
|---|---|---|
| 2026 | 2025 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $26,928 | $27,321 |
| Accounts receivable, less allowances for credit losses of $2,569 and $1,186, respectively | 44,099 | 41,970 |
| Inventories | 26,373 | 25,365 |
| Prepaid expenses and other current assets | 8,868 | 8,029 |
| Total current assets | 106,268 | 102,685 |
| Noncurrent assets | ||
| Property, plant and equipment, net | 30,613 | 32,333 |
| Deferred tax asset | 1,501 | 1,371 |
| Other assets | 19,155 | 18,324 |
| Customer relationships, net | 63,211 | 72,880 |
| Other intangibles, net | 20,136 | 23,995 |
| Goodwill | 186,863 | 181,760 |
| Total assets | $427,747 | $433,348 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $4,928 | $5,747 |
| Accrued payroll and benefits | 19,006 | 17,858 |
| Unearned revenues | 14,723 | 14,710 |
| Other accrued expenses | 17,616 | 24,601 |
| Term loan, current portion | 5,625 | 3,750 |
| Convertible senior notes, current portion, net of debt issuance costs | - | 97,297 |
| Total current liabilities | 61,898 | 163,963 |
| Noncurrent liabilities | ||
| Deferred tax liability | 20,085 | 20,181 |
| Other noncurrent liabilities | 13,662 | 12,472 |
| Term loan, noncurrent portion, net of debt issuance costs | 61,357 | 66,902 |
| Revolving line of credit | 84,500 | 10,000 |
| Total liabilities | 241,502 | 273,518 |
| Commitments and Contingencies (Note 13) | ||
| Stockholders’ equity | ||
| Common stock, no par value; authorized 25,000,000 shares; issued and outstanding, 5,524,931 and 5,455,421 shares, respectively | 375,348 | 358,541 |
| (Accumulated deficit) | (185,747) | (188,936) |
| Accumulated other comprehensive (loss) | (3,356) | (9,775) |
| Total stockholders’ equity | 186,245 | 159,830 |
| Total liabilities and stockholders’ equity | $427,747 | $433,348 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.